MICHAEL A. HAJOST - 07 Feb 2024 Form 4 Insider Report for Danimer Scientific, Inc. (DNMRQ)

Role: Chief Financial Officer
Signature: /s/ Stephen A. Martin, attorney-in-fact
Issuer symbol: DNMRQ
Transactions as of: 07 Feb 2024
Net transactions value: -$7,970
Form type: 4
Filing time: 08 Feb 2024, 17:00:12 UTC
Previous filing: 02 Mar 2023
Next filing: 05 Apr 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	DNMR	Class A Common Stock	Options Exercise		+34,364	+70%		83,140	07 Feb 2024	Direct	F1
transaction	DNMR	Class A Common Stock	Tax liability	$7,970	-12,076	-15%	$0.6600	71,064	07 Feb 2024	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	DNMR	RSU Award	Options Exercise	$0	-34,364	-50%	$0.000000	34,364	07 Feb 2024	Class A Common Stock	34,364		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units convert into common stock on a one-for-one basis.
F2	On March 31, 2022, the reporting person was granted 103,092 restricted stock units. 34,364 restricted stock units are vesting on February 7, 2023, February 7, 2024, and February 7, 2025.